Boston University Clarifies Its Covid Research: Variant Was Less Deadly


The U.K.’s Daily Mail tabloid newspaper stirred controversy by saying Boston University had engineered an artificial covid variant with an “80% kill rate,” the Boston Globe notes. The university has responded aggressively, and noted its experiments actually made the virus less dangerous.


CIDRAP:
Lab-Made SARS-CoV-2 Study Prompts Gain-Of-Function Questions 


Media reports claimed that the study included gain-of-function experiments, which have sparked concerns about dual-use and accidental release, especially in light of safety lapses at federal research facilities. In 2016, a federal advisory group commissioned an extensive risk assessment that it used to issue its final guidance. Gain-of-function research involves manipulating organisms to increase their transmissibility, virulence, immunogenicity, or other capabilities. “Dual-use” refers to experiments that can be used for both good and ill. (Schnirring, 10/18)

Experts are warning of a variant storm —


The Washington Post:
XBB, BQ.1.1, BA.2.75.2 — A Variant Swarm Could Fuel A Winter Surge


Instead of a single ominous variant lurking on the horizon, experts are nervously eyeing a swarm of viruses — and a new evolutionary phase in the pandemic. This time, it’s unlikely we will be barraged with a new collection of Greek alphabet variants. Instead, one or more of the multiple versions of the omicron variant that keep popping up could drive the next wave. They are different flavors of omicron, but eerily alike — adorned with a similar combination of mutations. Each new subvariant seems to outdo the last in its ability to dodge immune defenses. (Johnson, 10/18)


This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.



Source link

Ozinize
Logo
Shopping cart